Want to see JP:4536 full AI Analyst Report?
Santen Pharmaceutical Co (4536) Revenue
Santen Pharmaceutical Co Revenue
Santen Pharmaceutical Co had a revenue of 68.96B in the quarter ending Jun 30, 2026, with -14.72%. This bring the company's revenue in the last twelve months to 291.84B, Increased 0.08%. In the fiscal year ending Mar 31, 2026, Santen Pharmaceutical Co had annual revenue of 291.62B with -2.79% growth.
- Revenue (ttm)
- 291.84B
- Revenue Growth
- -0.72%
- P/S Ratio
- 1.97
- Revenue/Employee
- JPY 73,493,952
- Employees
- 3,968
- Market Cap
- JPY 574.81B
Revenue Chart
Santen Pharmaceutical Co Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 291.62B | -8.38B | -2.79% |
| Mar 31, 2026 | 300.00B | -1.96B | -0.65% |
| Mar 31, 2025 | 301.96B | 22.93B | 8.22% |
| Mar 31, 2024 | 279.04B | 12.78B | 4.80% |
| Mar 31, 2023 | 266.26B | 16.65B | 6.67% |
| Mar 31, 2022 | 249.60B | 8.05B | 3.33% |
| Mar 31, 2021 | 241.56B | 7.53B | 3.22% |
| Mar 31, 2020 | 234.03B | 9.08B | 4.04% |
| Mar 31, 2019 | 224.94B | 25.85B | 12.98% |
| Mar 31, 2017 | 199.10B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.